Your browser doesn't support javascript.
loading
Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.
Ledlie, Shaleesa; Ricci, Christina; Pan, Chunshen; Rojas, Andrey; Khromava, Alena; Li, Lin.
Afiliación
  • Ledlie S; Epidemiology and Benefit Risk, Sanofi Pasteur, North York, Ontario, Canada. Electronic address: Shaleesa.ledlie@outlook.com.
  • Ricci C; Epidemiology and Benefit Risk, Sanofi Pasteur, North York, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. Electronic address: christina.ricci@mail.utoronto.ca.
  • Pan C; Epidemiology and Benefit Risk, Sanofi US, Bridgewater, NJ, USA. Electronic address: Chunshen.Pan@sanofi.com.
  • Rojas A; Global Pharmacovigilance, Sanofi Pasteur, Bogota, Colombia. Electronic address: Andrey.Rojas@sanofi.com.
  • Khromava A; Epidemiology and Benefit Risk, Sanofi Pasteur, North York, Ontario, Canada. Electronic address: Alena.Khromava@sanofi.com.
  • Li L; Epidemiology and Benefit Risk, Sanofi US, Bridgewater, NJ, USA. Electronic address: Lin.Li@sanofi.com.
Vaccine ; 40(5): 742-751, 2022 01 31.
Article en En | MEDLINE | ID: mdl-34996642

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fiebre Amarilla / Vacuna contra la Fiebre Amarilla Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fiebre Amarilla / Vacuna contra la Fiebre Amarilla Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article